The clinical trial is designed to establish exactly how well this new vaccine can provide hope for a happier and longer life for our beloved dogs.
Norwalk, CT (PRWEB) October 10, 2013
Nationally recognized veterinary oncologist Dr. Gerald Post, owner of The Veterinary Cancer Center, is calling for owners of dogs with lymphoma in the region to find out if their dogs qualify to take part in clinical trials for a promising new vaccine that has been shown to diminish the effects of multiple types of cancer in dogs, cats and horses.
"Because it offers such promise for helping dogs with lymphoma, we are thrilled to be a part of this groundbreaking study," said Dr. Post. "This is an exciting and hopeful opportunity for tri-state pet owners and their dogs. The clinical trial is designed to establish exactly how well this new vaccine can provide hope for a happier and longer life for our beloved dogs."
Owners of dogs with lymphoma should check with their family veterinarian to determine if their dog’s disease meets the requirements for the clinical trial of the vaccine.
Florida-based Veterinary Oncology Services, in conjunction with leading biotechnology firm, Morphogenesis Inc., developed the cancer vaccine.
Along with Dr. Post’s clinic, the vaccine is now in clinical trials with other select leading veterinarians in Florida and Georgia, with other sites pending.
The vaccine treatment teaches the immune system to identify and attack the tumor cells without harmful side effects to the patient.
About The Veterinary Cancer Center
The Veterinary Cancer Center (The VCC) is a specialized veterinary practice located in Norwalk, CT, dedicated to the diagnosis and treatment of cancer in animals. The VCC is a state-of-the-art hospital, and is the largest stand-alone veterinary comparative oncology center in the United States. The staff includes nationally recognized oncologists, led by Dr. Gerald Post, DACVIM. The VCC's mission is to give hope to pet owners by pursuing better ways to diagnose, treat, and prevent cancer in all animals. For more information, please visit http://www.vcchope.com or 203-838-6626.
About Morphogenesis-Inc and Veterinary Oncology Services
Morphogenesis is a privately-held biotechnology company structured to serve the rapidly growing cell therapy, biologics and tissue engineering markets. Morphogenesis has developed a multi-indication cancer therapy which educates the immune system to attack tumor cells throughout the body without damaging other cells or systems. Its subsidiary, Veterinary Oncology Services, Inc., assists veterinary physicians in providing this non-toxic, personalized treatment for many types of cancers in cats, dogs and horses. For more information, please visit http://www.veterinaryoncologyservices.com or 813-877-7896 http://www.morphogenesis-inc.com or call 813-875-6600.